These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32894083)

  • 1. Identification of a novel subgroup of endometrial cancer patients with loss of thyroid hormone receptor beta expression and improved survival.
    Piqué DG; Greally JM; Mar JC
    BMC Cancer; 2020 Sep; 20(1):857. PubMed ID: 32894083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
    Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
    J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival.
    Mauland KK; Wik E; Hoivik EA; Kusonmano K; Halle MK; Berg A; Haugland HK; Øyan AM; Kalland KH; Stefansson IM; Akslen LA; Krakstad C; Trovik J; Werner HM; Salvesen HB
    Oncotarget; 2017 Feb; 8(6):9696-9707. PubMed ID: 28039471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
    Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
    J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.
    van Weelden WJ; Lalisang RI; Bulten J; Lindemann K; van Beekhuizen HJ; Trum H; Boll D; Werner HMJ; van Lonkhuijzen LRCW; Yigit R; Forsse D; Witteveen PO; Galaal K; van Ginkel A; Bignotti E; Weinberger V; Sweegers S; Kroep JR; Cabrera S; Snijders MPLM; Inda MA; Eriksson AGZ; ; Krakstad C; Romano A; van de Stolpe A; Pijnenborg JMA
    Am J Obstet Gynecol; 2021 Oct; 225(4):407.e1-407.e16. PubMed ID: 34019887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network.
    Zhao D; Ren C; Yao Y; Wang Q; Li F; Li Y; Jiang A; Wang G
    J Cell Biochem; 2020 Mar; 121(3):2437-2446. PubMed ID: 31692050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.
    Dong Y; Si JW; Li WT; Liang L; Zhao J; Zhou M; Li D; Li T
    Int J Clin Exp Pathol; 2015; 8(3):2864-75. PubMed ID: 26045795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Key Prognostic-Related miRNA-mRNA Pairs in the Progression of Endometrial Carcinoma.
    Dong Y; Zhang T; Li X; Yu F; Yu H; Shao S
    Gynecol Obstet Invest; 2022; 87(1):12-21. PubMed ID: 35081534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of the Prognosis Predicting Signature for Endometrial Cancer Patient.
    Tang J; Ma W; Luo L
    Med Sci Monit; 2019 Nov; 25():8248-8259. PubMed ID: 31678981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression.
    Felix AS; Stone RA; Chivukula M; Bowser R; Parwani AV; Linkov F; Edwards RP; Weissfeld JL
    Int J Cancer; 2012 Jul; 131(2):E114-21. PubMed ID: 22025313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel miRNA markers for the diagnosis and prognosis of endometrial cancer.
    Wang Q; Xu K; Tong Y; Dai X; Xu T; He D; Ying J
    J Cell Mol Med; 2020 Apr; 24(8):4533-4546. PubMed ID: 32150330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CKMT1A is a novel potential prognostic biomarker in patients with endometrial cancer.
    Wang Y; Zhao S; Qin Q; Gao X; Zhang X; Zhang M; Jiang Y; Ji X; Zhu H; Zhao X; Li H
    PLoS One; 2022; 17(1):e0262000. PubMed ID: 35077462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.
    Zhou M; Zhang Z; Zhao H; Bao S; Sun J
    BMC Cancer; 2018 Jan; 18(1):39. PubMed ID: 29304762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools.
    Besso MJ; Montivero L; Lacunza E; Argibay MC; Abba M; Furlong LI; Colas E; Gil-Moreno A; Reventos J; Bello R; Vazquez-Levin MH
    Oncol Rep; 2020 Sep; 44(3):873-886. PubMed ID: 32705231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of endometrial cancer molecular subtypes using a whole exome-sequencing based single-method approach.
    Mustea A; Ralser DJ; Egger EK; Ziehm U; Vivas S; Brock S; Jackson D; Condic M; Rauschendorf MA; Würfel P; Dombrowski F; Otten LA; Sun P; Laib A; Cordova MC; Hartmann R; Stein MA; Koensgen D; Stope MB
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):367. PubMed ID: 39052171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
    Yang Q; Yu B; Sun J
    Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
    Zhang Q; Xia T; Qi C; Du J; Ye C
    BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.
    Jamieson A; Huvila J; Chiu D; Thompson EF; Scott S; Salvador S; Vicus D; Helpman L; Gotlieb W; Kean S; Samouelian V; Köbel M; Kinloch M; Parra-Harran C; Offman S; Grondin K; Irving J; Lum A; Senz J; Leung S; McConechy MK; Plante M; Kommoss S; Huntsman DG; Talhouk A; Gilks CB; McAlpine JN
    Mod Pathol; 2023 Apr; 36(4):100085. PubMed ID: 36788084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC).
    Jazdzewski K; Boguslawska J; Jendrzejewski J; Liyanarachchi S; Pachucki J; Wardyn KA; Nauman A; de la Chapelle A
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E546-53. PubMed ID: 21159845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.